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Dermatitis Herpetiformis
Rachel Wolf BSN, RN, SNP
Otterbein University, Westerville, Ohio
Signs and Symptoms
The main sign that accompanies DH is
the eruption of intensely pruritic
papulovesical lesions that typically
present bilaterally on the elbows,
knees, buttocks, neck, and scalp
(Criado et al., 2012). They may appear
on the upper back, abdomen, groin,
and face as well. The lesions are small
blisters that resemble those that are
caused by the herpes simplex virus. By
the time a patient seeks evaluation by
a care provider, the lesions have often
been scratched so much as to cause
erosions, excoriation, and or crusted
papules (Junkins-Hopkins, 2010). The
surrounding area may have erythema
and or urticarial plaques. Patients may
have areas of hyperpigmentation from
previous outbreaks (Bonciani et al.,
2012). The breakouts are of a chronic
nature and will have periods of flare
ups and remission. The periods of
remission do not typically last long
than several weeks (Criado et al.,
2012). The hallmark symptom that
patients with DH report is extremely
intense itching. They may report
experiencing the itching, a burning
and or a stinging sensation up to 12
hours prior to eruptions on the skin.

Pathophysiology
The pathophysiology of DH involves genetics, environment, and an immune
response. Nearly all patients with DH are carriers of either the human leukocyte
antigen (HLA) DQ2 or HLA DQ8 alleles (Bonciani et el., 2012). These are the same
alleles the are present in patients with CD. The HLA DQ2 is the more commonly
carried allele. The presences of one of these alleles is so strongly associated with DH
and CD that the sensitivity of the test is nearly 100%. The absence of either allele
nearly excludes a diagnosis of either disease. Studies performed using monozygotic
twins and analysis of the incidence of the alleles among first-degree relatives shows
the strong genetics factors are at play in the development of DH and CD (Bolotin &
Petronic-Rosic, 2010).
The environment required to induce the reaction involved with DH is a diet
containing gluten. Gluten is a protein composite found in wheat, rye, and barley (
Bonciani et al., 2012). Gliadin, a component of gluten, is indigestible, and an alcoholsoluble protein that leads to the immune reaction involved in DH and CD.
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The immune response in DH is seen in biopsies of active lesions, as well as
perilesional skin (Bonciani et al., 2012). A biopsy positive for granular IgA in the
dermal papillae and may also be present in the basement membrane (JunkinsHopkins, 2010). It is believed to be IgA that helps neutrophils infiltrate the papillae
and the basement membrane (Nakajima, 2012). Immunofluorescence studies are
used for definitive diagnosis and to rule out similar presenting disorders of the
skin such as bullous dermatosis (Bolotin & Petronic-Rosic, 2011).
Serum studies can be used to help in the diagnostic process. They evaluate for the
presence of circulating IgA antibodies to endomysium (Bolotin & Petronic-Rosic,
2011). The IgA antibodies found in DH patients are specific for epidermal-specific
transglutaminase (TG), known as anti-epidermal transglutaminase (eTG). Serum
studies measuring anti-eTG are 95% sensitive for DH.
The immune response to gluten in the DH patient is evidenced by the inflammatory
infiltrate composed of neutrophils on the dermal papillary tips seen on biopsy, as
well as IgA deposits (Bonciani et al., 2012). Lesions are composed are also
composed of eosinophils and fibrin which help to form microabscesses. The
inflammation triggering T cells are also present on the lesions and perilesional
skin, further evidence of immune response.

Dermatitis Herpetiformis: An Introduction
Dermatitis herpetiformis (DH) is a chronic autoimmune disease that manifests on the
skin (Bolotin & Petronic-Rosic, 2011, p. 1017). DH presents with erythematous
papules that often have vesicles (p. 1020). The lesions are intensely pruritic, so much
so that they are often excoriated by the time a patient is evaluated by a physician.
They have a distinct presentation erupting symmetrically on the extensor surfaces of
the upper and lower extremities. Locations include the elbows, knees, scalp, and
buttocks (p. 1020).
DH is considered an extra-intestinal manifestation of celiac disease (CD)
(Krishnareddy, 2013). DH and CD are both autoimmune gluten sensitivities that are
mediated by immunoglobulin A (IgA) (Bolotin & Petronic-Rosic, 2011, p. 1017). Key
differences include the main autoantigens involved. DH involves epidermal
transglutaminase (eTG) while CD involves tissue transglutaminase (tTG). A definitive
diagnosis of DH is made with a biopsy taken from perilesional skin that is positive for
granular deposition of IgA in the dermal papillae and the basement membrane under
direct immunofluorescence (p. 1020). A diagnosis of CD begins with serologic testing
(Autodore, Verma, & Gupta, 2012, p. 272). . If those tests are positive for CD related
immunoglobulins, a endoscopic biopsy of the duodenum is in order. If CD is present,
the biopsies will show villous atrophy. Both diseases are associated with human
leukocyte antigen (HLA) (Bolotin & Petronic-Rosic, 2011, p. 1019). Genetic tests show
HLA-DQ2 and HLA-DQ8 in effected carriers. Both diseases are treated with a life-long
gluten free diet (GFD). DH treatment may include the use of the antibiotic dapsone
for an extended period of time.
DH is of particular importance to myself because I have struggled with finding a
diagnosis for the symptoms I have been experiencing over the past few years. DH was
first considered a possibility for me after I presented to a dermatologist for the
second time in a matter of months with incredibly pruritic lesions. No matter what I
did they would not go away. I ended up seeing a gastroenterologist, but my
neurologist has been the most helpful in my journey. She has celiac disease and
completed the serologic testing needed for diagnosis. I tested positive for the genes
involved with CD, but the immunologic testing was negative. She recommended I
start a GFD to alleviate they various symptoms I was having that included others that
just the skin presentation. After going back and forth with the necessity of a GFD
when I did not have positive serologic studies, I realized that my thinking was much
clearer when following the diet. I committed to following it. I did however continue to
break out with the pruritic lesions. After multiple courses of prednisone I again
returned to the dermatologist. He said that he believed DH is the correct diagnosis.
After some more research I found that serologic studies are not always positive in
those with DH, but it is still a manifestation of CD.
There is an abundance of literature on CD. It is my hope that through this project
others practitioners will be provided with information on a disease they might not
have otherwise heard of.

Nursing Implications
The pathophysiology of DH has
significant implications for nurses that
diagnose and care for these patients.
Being able to provide an accurate
diagnosis is the first step. Prescribing
treatment and educating patients on
the intricacies of a gluten free diet and
the medication options available can
be a involved process. The importance
of a life-long gluten free diet must be
communicated. Poor compliance has
been associate with low levels of
information on the GFD (Fasano,
2012). Even if remission is seen with
the adjunct of medication, the diet is
the only way to keep the flares from
returning.
Currently the main pharmacologic
treatment of CD is dapsone. Even
following a strict GFD, IgA deposits
within the skin are seen up to several
years after its initiation (Bolotin &
Petronic-Rosic, 2011). Dapsone has
both anti-inflammatory and
antibacterial properties that inhibit the
recruitment of neutrophils. Dapsone
therapy helps to resolve the active
lesions within days of beginning
treatment. There are drawbacks to its
use, including methemoglobinemia
and agranulocytosis. These are serious
conditions that require frequent
monitoring. If the patient is unable to
tolerate dapsone therapy, sulfasalzine
or sulfamethoxypridazine may be
used.
DH is a disease that can present like
many other skin diseases. To be able to
accurately diagnose it can make an
incredible difference in a patient’s life.
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